Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Public ClinicalTrials.gov record NCT01023958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Phase II Trial of Intravenous BI 6727 in Patients With Locally Advanced, Metastatic or Recurrent Urothelial Cancer of the Bladder, Renal Pelvis, or Ureters After Failure of Prior Chemotherapy
Study identification
- NCT ID
- NCT01023958
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- BI 6727, IV infusion Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2009
- Primary completion
- Sep 18, 2011
- Completion
- Sep 18, 2011
- Last update posted
- Nov 21, 2017
2009 – 2011
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1230.2.5 Boehringer Ingelheim Investigational Site | Beverly Hills | California | — | — |
| 1230.2.10 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1230.2.34 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1230.2.29 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 1230.2.6 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1230.2.17 Boehringer Ingelheim Investigational Site | Joliet | Illinois | — | — |
| 1230.2.24 Boehringer Ingelheim Investigational Site | Metairie | Louisiana | — | — |
| 1230.2.1 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1230.2.25 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 1230.2.36 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 1230.2.19 Boehringer Ingelheim Investigational Site | Lebanon | New Hampshire | — | — |
| 1230.2.20 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1230.2.23 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1230.2.12 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1230.2.4 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1230.2.38 Boehringer Ingelheim Investigational Site | Beaumont | Texas | — | — |
| 1230.2.41 Boehringer Ingelheim Investigational Site | Tyler | Texas | — | — |
| 1230.2.43 Boehringer Ingelheim Investigational Site | Webster | Texas | — | — |
| 1230.2.44 Boehringer Ingelheim Investigational Site | Fairfax | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01023958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 21, 2017 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01023958 live on ClinicalTrials.gov.